Second Sight ’s Argus II Retinal Prosthesis Implanted in First Patient in Asia
--Underscores Second Sight’s Commitment to Expansion in Asia--
SYLMAR, Calif. -- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, today announced that the Argus® II Retinal Prosthesis System ("Argus II") has been implanted in the first patient in Asia through an exclusive distribution partnership with Orient Europharma Co., Ltd. (OEP) and with charitable support from the Hong-Lu Foundation in Taiwan. The Argus II was provided under special import permits authorized by the Taiwan Food and Drug Administration (TFDA).
- Category: Medical Devices
- Published: 13 April 2017
- Written by Editor